1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Asia Pacific Anti-viral therapies Market – By Type

1.3.2        Asia Pacific Anti-Viral Therapies Market – By Mechanism of Action

1.3.3        Asia Pacific Anti-Viral Therapies Market– By Application

1.3.4        Asia Pacific Anti-Viral Therapies Market – By Country

2.          Asia Pacific Anti-Viral Therapies Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Asia Pacific Anti-Viral Therapies Market – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        Anti-Viral Therapies Market – Asia Pacific PEST Analysis

4.3        Expert Opinion

5.          Asia Pacific Anti-Viral Therapies Market -  Key Market Dynamics

5.1        Key Market Drivers

5.1.1        Increasing R&D Expenditures in Pharmaceutical Companies

5.1.2        Rising Government Support for Research Activities and Clinical Trials

5.2        Market Restraints

5.2.1        High Cost of Drug Development

5.3        Market Opportunities

5.3.1        Emerging Markets

5.4        Future Trends

5.4.1        Growing Emphasis on Launching Anti-Viral Agents

5.5        Impact analysis

6.          Anti-Viral Therapies Market – Asia Pacific Analysis

6.1        Asia Pacific Anti-Viral Therapies Market Revenue Forecasts and Analysis

7.          Asia Pacific Anti-Viral Therapies Market Analysis and Forecasts To 2027 – By Type

7.1        Overview

7.2        Asia Pacific Anti-Viral Therapies Market, By Type 2019 & 2027 (%)

7.2.1        Asia Pacific Anti-Viral Therapies Market Revenue and Forecasts to 2027, By Type (US$ Mn)

7.3        Generic Drugs

7.3.1        Overview

7.3.2        Asia Pacific Generic Drugs Market Revenue and Forecast to 2027 (US$ Mn)

7.4        Branded Drugs

7.4.1        Overview

7.4.1.1         Asia Pacific Branded Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

8.          Asia Pacific Anti-Viral Therapies Market Analysis – By Mechanism of Action

8.1        Overview

8.2        Asia Pacific Anti-Viral Therapies Market, By Mechanism of Action 2019-2027 (%)

8.2.1        Asia Pacific Anti-Viral Therapies Market Revenue and Forecasts to 2027, By Mechanism of Action (US$ Mn)

8.3        Nucleotide Polymerase Inhibitor

8.3.1        Overview

8.3.2        Asia Pacific Nucleotide Polymerase Inhibitor Market Revenue and Forecasts to 2027 (US$ Mn)

8.4        Reverse Transcriptase Inhibitors

8.4.1        Overview

8.4.2        Asia Pacific Reverse Transcriptase Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)

8.5        Protease Inhibitors

8.5.1        Overview

8.5.2        Asia Pacific Protease Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)

8.6        Others

8.6.1        Overview

8.6.2        Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

9.          Asia Pacific Anti-Viral Therapies Market Analysis and Forecasts To 2027 – By Application

9.1        Overview

9.2        Asia Pacific Anti-Viral Therapies Market, By Application 2019 & 2027 (%)

9.2.1        Asia Pacific Anti-Viral Therapies Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.3        HIV

9.3.1        Overview

9.3.2        Asia Pacific HIV Market Revenue and Forecast to 2027 (US$ Mn)

9.4        Hepatitis

9.4.1        Overview

9.4.2        Asia Pacific Hepatitis Market Revenue and Forecasts to 2027 (US$ Mn)

9.5        Herpes

9.5.1        Overview

9.5.2        Asia Pacific Herpes Market Revenue and Forecasts to 2027 (US$ Mn)

9.6        Influenza

9.6.1        Overview

9.6.2        Asia Pacific Influenza Market Revenue and Forecasts to 2027 (US$ Mn)

9.7        Other Applications

9.7.1        Overview

9.7.2        Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

10.       Anti-Viral Therapies Market Revenue and Forecasts To 2027 – Geographical Analysis

10.1     Asia Pacific Anti-Viral Therapies Market Revenue and Forecasts To 2027

10.1.1     Overview

10.1.2     Asia Pacific: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)

10.1.3     Asia Pacific: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)

10.1.4     Asia Pacific: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)

10.1.5     Asia Pacific: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)

10.1.6     Asia Pacific: Anti-Viral Therapies Market, by Country, 2019 & 2027 (%)

10.1.7     China: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1       China: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2       China: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)

10.1.7.3       China: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)

10.1.7.4       China: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)

10.1.8     Japan: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1       Japan: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2       Japan: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)

10.1.8.3       Japan: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)

10.1.8.4       Japan: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)

10.1.9     India: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1       India: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2       India: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)

10.1.9.3       India: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)

10.1.9.4       India: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)

10.1.10   South Korea: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.1    South Korea: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.2    South Korea: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)

10.1.10.3    South Korea: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)

10.1.10.4    South Korea: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)

10.1.11   Australia: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.1    Australia: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.2    Australia: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)

10.1.11.3    Australia: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)

10.1.11.4    Australia: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)

11.       Impact of COVID-19 Pandemic on Asia Pacific Anti-viral therapies Market

11.1     Asia Pacific: Impact Assessment of COVID-19 Pandemic

12.       Company Profiles

12.1     Aurobindo Pharma Ltd

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2     GlaxoSmithKline plc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3     AstraZeneca

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4     F. HOFFMANN-LA ROCHE LTD.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5     AbbVie Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

13.       Appendix

13.1     About The Insight Partners

13.2     Glossary of Terms

LIST OF TABLES

Table 1.            Asia Pacific Anti-Viral Therapies Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 2.            Asia Pacific Anti-Viral Therapies Market Revenue and Forecasts To 2027, By Mechanism of Action (US$ Mn)

Table 3.            Asia Pacific Anti-Viral Therapies Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 4.            Asia Pacific Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 5.            Asia Pacific Anti-Viral Therapies Market, by Mechanism of Action – Revenue and Forecast to 2027 (USD Million)

Table 6.            Asia Pacific Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 7.            China Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.            China Anti-Viral Therapies Market, by Mechanism of Action– Revenue and Forecast to 2027 (USD Million)

Table 9.            China Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 10.         Japan Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11.         Japan Anti-Viral Therapies Market, by Mechanism of Action– Revenue and Forecast to 2027 (USD Million)

Table 12.         Japan Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 13.         India Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14.         India Anti-Viral Therapies Market, by Mechanism of Action– Revenue and Forecast to 2027 (USD Million)

Table 15.         India Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 16.         South Korea Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 17.         South Korea Anti-Viral Therapies Market, by Mechanism of Action– Revenue and Forecast to 2027  (USD Million)

Table 18.         South Korea Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 19.         Australia Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 20.         Australia Anti-Viral Therapies Market, by Mechanism of Action– Revenue and Forecast to 2027 (USD Million)

Table 21.         Australia Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 22.         Glossary of Terms, Anti-Viral Therapies Market

LIST OF FIGURES

Figure 1.          Anti-Viral Therapies Market Segmentation

Figure 2.          Asia Pacific Anti-Viral Therapies Market Overview

Figure 3.          Branded Drugs Segment Held Largest Share of Anti-Viral Therapies Market

Figure 4.          China is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.          Asia Pacific Anti-Viral Therapies Market - Leading Country Markets (US$ Mn)

Figure 6.          Anti-Viral Therapies Market – Asia Pacific PEST Analysis

Figure 7.          Anti-Viral Therapies Market Impact Analysis of Driver and Restraints

Figure 8.          Asia Pacific Anti-viral therapies Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.          Asia Pacific Anti-Viral Therapies Market, By Type 2019 & 2027 (%)

Figure 10.        Asia Pacific Generic Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        Asia Pacific Branded Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        Asia Pacific Anti-Viral Therapies Market, by Mechanism of Action 2019 & 2027 (%)

Figure 13.        Asia Pacific Nucleotide Polymerase Inhibitor Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        Asia Pacific Reverse Transcriptase Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        Asia Pacific Protease Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.        Asia Pacific Anti-Viral Therapies Market, By Application 2019 & 2027 (%)

Figure 18.        Asia Pacific HIV Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        Asia Pacific Hepatitis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        Asia Pacific Herpes Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        Asia Pacific Influenza Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.        Asia Pacific: Anti-Viral Therapies Market, by Key Country – Revenue (2019) (USD Million)

Figure 24.        Asia Pacific Anti-Viral Therapies Market Revenue and Forecast to 2027 (USD Million)

Figure 25.        China: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        Japan: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        India: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        South Korea: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        Australia: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        Impact of COVID-19 Pandemic in Asia-Pacific Country Markets